Artelo Biosciences, Inc.
ARTL
$9.35
-$0.18-1.89%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 10.51% | -5.42% | -2.81% | -19.99% | -21.36% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.82% | -3.22% | 1.79% | -6.20% | 10.14% |
| Operating Income | 3.82% | 3.22% | -1.79% | 6.20% | -10.14% |
| Income Before Tax | -0.62% | -1.16% | -5.78% | 4.54% | -10.62% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.62% | -1.16% | -5.78% | 4.54% | -10.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -0.62% | -1.16% | -5.78% | 4.54% | -10.62% |
| EBIT | 3.82% | 3.22% | -1.79% | 6.20% | -10.14% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 5.69% | 8.06% | 5.82% | 17.67% | 2.88% |
| Normalized Basic EPS | 9.34% | 12.22% | 9.42% | 19.04% | 3.25% |
| EPS Diluted | 5.69% | 8.06% | 5.85% | 17.69% | 2.91% |
| Normalized Diluted EPS | 9.34% | 12.22% | 9.42% | 19.04% | 3.25% |
| Average Basic Shares Outstanding | 4.78% | -16.07% | -14.37% | -12.43% | -14.11% |
| Average Diluted Shares Outstanding | 4.78% | -16.07% | -14.37% | -12.43% | -14.11% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |